BioTech Weekly - Oct 06-19, 2025

🔬 Top Biotech NewsHere are the key developments in biotechnology this week:1️⃣ StockWatch: After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results 2️⃣ GlycoNet/Alberta Innovates – Driving health research to market for Alberta’s future 3️⃣ AI is changing how we quantify pain 4️⃣ BIO on the American Road: Biotech innovation and job growth in Illinois 5️⃣ The race to make the perfect baby is creating an ethical mess 6️⃣ Sick Cells: Elevating the patient voice 7️⃣ Enhancing Speed and Scalability in Upstream Bioprocessing of Monoclonal and Bispecific Antibodies 8️⃣ How aging clocks can help us understand why we age—and if we can reverse it 9️⃣ Syngene International Invests in Dedicated Peptide Laboratory and Advanced Automation 🔟 Genome Maintains 3D Structure During Cell Division, Contrary to Long-Held Belief 1️⃣1️⃣ This startup thinks slime mold can help us design better cities 1️⃣2️⃣ The quest to find out how our bodies react to extreme temperatures 1️⃣3️⃣ Senators seek patent clarity to support innovation 1️⃣4️⃣ Take our quiz: How much do you know about antimicrobial resistance? 1️⃣5️⃣ Augurex – Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx💡 From gene editing to glycomics, AI-driven diagnostics, and biotech policy — innovation is reshaping health and life sciences faster than ever.#Biotech #Biotechnology #Science #Innovation #Healthcare #Research #LifeSciences #AIinHealthcare #GeneEditing #Pharma

There are no comments yet.

Please log in to write the first comment.